KRTAP21-2
gene geneOn this page
Also known as KAP21.2
Summary
KRTAP21-2 (keratin associated protein 21-2, HGNC:18946) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 21-2 (Q3LI59). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 337978 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 9 total
- MANE Select transcript:
NM_181617
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18946 |
| Approved symbol | KRTAP21-2 |
| Name | keratin associated protein 21-2 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP21.2 |
| Ensembl gene | ENSG00000187026 |
| Ensembl biotype | protein_coding |
| Entrez | 337978 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000333892
RefSeq mRNA: 1 — MANE Select: NM_181617
NM_181617
CCDS: CCDS13605
Canonical transcript exons
ENST00000333892 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001339702 | 30746794 | 30747259 |
Expression profiles
Bgee: expression breadth broad, 23 present calls, max score 98.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0760 / max 16.7770, expressed in 18 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190128 | 0.0760 | 18 |
Top tissues by expression
92 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 98.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.69 | gold quality |
| left testis | UBERON:0004533 | 56.12 | gold quality |
| testis | UBERON:0000473 | 55.29 | gold quality |
| right testis | UBERON:0004534 | 55.00 | gold quality |
| skin of abdomen | UBERON:0001416 | 42.39 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| zone of skin | UBERON:0000014 | 37.16 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right uterine tube | UBERON:0001302 | 35.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| skin of leg | UBERON:0001511 | 33.14 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| islet of Langerhans | UBERON:0000006 | 31.43 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| uterine cervix | UBERON:0000002 | 26.76 | gold quality |
| leukocyte | CL:0000738 | 26.63 | gold quality |
| pancreas | UBERON:0001264 | 26.55 | gold quality |
| monocyte | CL:0000576 | 26.54 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.48 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 21-2 — Q3LI59 (reviewed: Q3LI59)
All UniProt accessions (1): Q3LI59
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
RefSeq proteins (1): NP_853648* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021743 | KRTAP_type8/19/20/21/22 | Family |
Pfam: PF11759
UniProt features (2 total): chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI59-F1 | 35.38 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 9 (showing top):
chr21q22, TGGAAA_NFAT_Q4_01, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, PAX3_TARGET_GENES, TATAAA_TATA_01
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
294 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP21-2 | KRTAP21-3 | Q3LHN1 | 785 |
| KRTAP21-2 | KRTAP21-1 | Q3LI58 | 772 |
| KRTAP21-2 | KRTAP6-3 | Q3LI67 | 696 |
| KRTAP21-2 | KRTAP7-1 | Q8IUC3 | 623 |
| KRTAP21-2 | KRTAP6-1 | Q3LI64 | 621 |
| KRTAP21-2 | SCYGR1 | A0A286YEY9 | 621 |
| KRTAP21-2 | KRTAP19-6 | Q3LI70 | 621 |
| KRTAP21-2 | KRTAP15-1 | Q3LI76 | 621 |
| KRTAP21-2 | KRTAP20-1 | Q3LI63 | 608 |
| KRTAP21-2 | KRTAP22-1 | Q3MIV0 | 606 |
| KRTAP21-2 | KRTAP20-2 | Q3LI61 | 592 |
| KRTAP21-2 | LCA5L | O95447 | 585 |
| KRTAP21-2 | KRTAP8-1 | Q8IUC2 | 583 |
| KRTAP21-2 | KRTAP24-1 | Q3LI83 | 583 |
| KRTAP21-2 | KRTAP6-2 | Q3LI66 | 581 |
IntAct
88 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FOXD2 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | RNF38 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | ADAMTSL4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GATA2 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | PLSCR4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMN1 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLCNKA | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZIC1 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VENTX | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | RNF44 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | PRR13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | NTN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221A | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNRPC | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFEMP1 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | SMARCC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POU4F2 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | BEX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | TCF7L2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | LCE1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | LCE2A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | SPAG8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MKRN3 | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | DMRTB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | KRTAP26-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATXN1L | KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP21-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (30): KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid), KRTAP21-2 (Two-hybrid)
ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YEY9, A0A286YF01, A0A286YF46, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, O14633, P02438, P04459, P05687, P05688, P08131, P08175, P0DSO2, P20730, Q01642, Q01643, Q01644, Q01645, Q07627, Q3LI58, Q3LI59, Q3V2C1, Q5T750, Q5T752, Q5T754, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q8IUC1, Q8IUG1, Q9BQ66, Q9BYP8, Q9BYQ5, Q9BYQ6
Diamond homologs: Q3LI58, Q3LI59, Q925H4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 28 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 5 | 16.4× | 4e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
92 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30747124:A:AT | donor_gain | 0.8100 |
| 21:30747089:T:C | donor_gain | 0.8000 |
| 21:30747123:C:CT | donor_gain | 0.7500 |
| 21:30746972:T:C | donor_gain | 0.7200 |
| 21:30747071:T:TA | donor_gain | 0.6500 |
| 21:30747076:AG:A | donor_gain | 0.5500 |
| 21:30746981:G:C | donor_gain | 0.5200 |
| 21:30747130:AT:A | donor_gain | 0.5200 |
| 21:30747146:C:CA | donor_gain | 0.5200 |
| 21:30746972:T:TA | donor_gain | 0.5000 |
| 21:30746996:G:C | donor_gain | 0.5000 |
| 21:30747107:T:C | donor_gain | 0.5000 |
| 21:30747131:T:C | donor_gain | 0.4900 |
| 21:30746933:GATGA:G | donor_loss | 0.4700 |
| 21:30746938:C:A | donor_loss | 0.4700 |
| 21:30746939:C:G | donor_loss | 0.4700 |
| 21:30747090:C:CT | donor_gain | 0.4700 |
| 21:30747091:T:TT | donor_gain | 0.4700 |
| 21:30747106:AT:A | donor_gain | 0.4700 |
| 21:30746920:T:TC | acceptor_gain | 0.4600 |
| 21:30746940:T:C | donor_loss | 0.4600 |
| 21:30747077:G:C | donor_gain | 0.4600 |
| 21:30747047:T:C | donor_gain | 0.4400 |
| 21:30746861:T:C | acceptor_gain | 0.4100 |
| 21:30747122:A:AC | donor_gain | 0.4100 |
| 21:30746864:G:C | donor_gain | 0.4000 |
| 21:30747119:G:C | donor_gain | 0.4000 |
| 21:30747161:T:C | donor_gain | 0.4000 |
| 21:30746859:A:AC | donor_gain | 0.3900 |
| 21:30747118:AG:A | donor_gain | 0.3900 |
AlphaMissense
512 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000243330 (21:30748641 T>A,C), RS1003188637 (21:30748635 C>G), RS1004172493 (21:30747944 A>C), RS1004971152 (21:30747098 A>G), RS1005369352 (21:30746907 C>T), RS1006807028 (21:30746468 A>G), RS1006817061 (21:30746817 CTT>C), RS1008064705 (21:30747303 T>C), RS1009017056 (21:30747637 T>C), RS1009874733 (21:30746398 G>A), RS1011850395 (21:30747466 C>T), RS1012022664 (21:30747814 C>A), RS1012872339 (21:30746946 G>C), RS1013154840 (21:30747190 A>C,G,T), RS1013875635 (21:30748237 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| Thiram | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Asbestos, Serpentine | affects expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.